pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

310 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: phase 0 trial completion×type: earnings×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
phase 1 initiation
39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area
    • Oncology4
    • Cardiology4
    • Dermatology3
    • Pain2
    • Immunology1
    • Women's Health1
    • Pulmonology1

    Week of Apr 27, 2026

    50
    ›Apr 28, 2026earnings90d agoNOVARTIS AG earningsNOVARTIS AG

    Anticipated earnings call for NOVARTIS AG ($NVS).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings90d agoINCYTE CORP earningsINCYTE CORP

    Anticipated earnings call for INCYTE CORP ($INCY).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings90d agoECOLAB INC. earningsECOLAB INC.

    Anticipated earnings call for ECOLAB INC. ($ECL).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings90d agoOrion Group Holdings Inc earningsOrion Group Holdings Inc

    Anticipated earnings call for Orion Group Holdings Inc ($ORN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026phase 0 trial completion89d agoDana-Farber Cancer Institute Inc — atezolizumab (Phase 0 Trial Completion)atezolizumab

    Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer

    full page →atezolizumab →source: globaldata
    ›Apr 29, 2026earnings89d agoAbbVie Inc. earningsAbbVie Inc.

    Anticipated earnings call for AbbVie Inc. ($ABBV).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoASTRAZENECA PLC earningsASTRAZENECA PLC

    Anticipated earnings call for ASTRAZENECA PLC ($AZN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoGSK plc earningsGSK plc

    Anticipated earnings call for GSK plc ($GSK).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoREGENERON PHARMACEUTICALS, INC. earningsREGENERON PHARMACEUTICALS, INC.

    Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoTEVA PHARMACEUTICAL INDUSTRIES LTD earningsTEVA PHARMACEUTICAL INDUSTRIES LTD

    Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoGLAUKOS Corp earningsGLAUKOS Corp

    Anticipated earnings call for GLAUKOS Corp ($GKOS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoBIOGEN INC. earningsBIOGEN INC.

    Anticipated earnings call for BIOGEN INC. ($BIIB).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoBausch & Lomb Corp earningsBausch & Lomb Corp

    Anticipated earnings call for Bausch & Lomb Corp ($BLCO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoSBA COMMUNICATIONS CORP earningsSBA COMMUNICATIONS CORP

    Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoAGIOS PHARMACEUTICALS, INC. earningsAGIOS PHARMACEUTICALS, INC.

    Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoIONIS PHARMACEUTICALS INC earningsIONIS PHARMACEUTICALS INC

    Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoAvantor, Inc. earningsAvantor, Inc.

    Anticipated earnings call for Avantor, Inc. ($AVTR).

    full page →yahoo earnings ↗
    ›Apr 30, 2026phase 0 trial completion88d agoKunming Yan'an Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Central Nervous System. Indication: Pain

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoRuijin Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Central Nervous System, Dermatology. Indication: Burns, Pain, Sedation

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoSecond Affiliated Hospital of Anhui Medical University — yingtao shujie paste (Phase 0 Trial Completion)yingtao shujie paste

    Therapy area: Oncology, Women's Health. Indication: Breast Cancer, Breast Hyperplasia

    full page →yingtao shujie paste →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoAffiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Central Nervous System. Indication: Delirium

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoCivil Aviation General Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Cardiovascular, Respiratory. Indication: Ischemia Reperfusion Injury, Lung Disease

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoShanghai Jiao Tong University — insulin (Phase 0 Trial Completion)insulin

    Therapy area: Dermatology. Indication: Unspecified Dermatological Disorders

    full page →insulin →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoFoundation for the Promotion of Health and Biomedical Research of Valencia — Aquacel Ag + (Phase 0 Trial Completion)Aquacel Ag +

    Therapy area: Dermatology. Indication: Pressure Ulcers

    full page →Aquacel Ag + →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoYangzhou No.1 People's Hospital — dexamethasone (Phase 0 Trial Completion)dexamethasone

    Therapy area: Gastrointestinal. Indication: Post Operative Nausea And Vomiting

    full page →dexamethasone →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoHefei First People’s Hospital — ergothioneine (Phase 0 Trial Completion)ergothioneine

    Therapy area: Cardiovascular. Indication: Atherosclerosis

    full page →ergothioneine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoAffiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Central Nervous System. Indication: Delirium

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoUniversity of Utah — micronized progesterone (Phase 0 Trial Completion)micronized progesterone

    Therapy area: Central Nervous System. Indication: Substance (Drug) Abuse

    full page →micronized progesterone →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoAffiliated Hospital of Xuzhou Medical University — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Central Nervous System. Indication: Delirium

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoNational Key Research and Development Program — undisclosed sodium glucose cotransporter 2 inhibitor (Phase 0 Trial Completion)undisclosed sodium glucose cotransporter 2 inhibitor

    Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes

    full page →undisclosed sodium glucose cotransporter 2 inhibitor →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoUniversity of Southern California — methylprednisolone (Phase 0 Trial Completion)MEDROL

    Therapy area: Immunology. Indication: Drug Hypersensitivity Reactions

    full page →MEDROL →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoKey Projects of Science and Technology Department of Sichuan Province — dantrolene (Phase 0 Trial Completion)dantrolene

    Therapy area: Cardiovascular. Indication: Ischemia, Myocardial Ischemia, Ventricular Arrhythmia

    full page →dantrolene →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoBaylor College of Medicine — glycine (Phase 0 Trial Completion)glycine

    Therapy area: Central Nervous System. Indication: Alzheimer's Disease

    full page →glycine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoUniversity of Pennsylvania — ubidecarenone (Phase 0 Trial Completion)ubidecarenone

    Therapy area: Central Nervous System, Gastrointestinal. Indication: Crohn's Disease (Regional Enteritis), Fatigue

    full page →ubidecarenone →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoJiangsu Maoxing Technology Co Ltd — MT-026 (Phase 0 Trial Completion)MT-026

    Therapy area: Oncology. Indication: Glioma

    full page →MT-026 →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoFirst Affiliated Hospital of Anhui Medical University — esketamine (Phase 0 Trial Completion)esketamine

    Therapy area: Central Nervous System, Oncology. Indication: Post-Operative Pain, Thyroid Cancer

    full page →esketamine →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoInner Mongolia Aerospace Hospital — (bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12) (Phase 0 Trial Completion)(bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12)

    Therapy area: Cardiovascular, Gastrointestinal. Indication: Atherosclerosis, Irritable Bowel Syndrome

    full page →(bifidobacterium lactis V9 + lactobacillus paracasei LP007 + lactobacillus plantarum PP12) →source: globaldata
    ›Apr 30, 2026phase 0 trial completion88d agoFuning County People's Hospital — dexmedetomidine (Phase 0 Trial Completion)dexmedetomidine

    Therapy area: Central Nervous System, Gastrointestinal. Indication: Post Operative Nausea And Vomiting, Post-Operative Pain

    full page →dexmedetomidine →source: globaldata
    ›Apr 30, 2026earnings88d agoMERIT MEDICAL SYSTEMS INC earningsMERIT MEDICAL SYSTEMS INC

    Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoMerck & Co., Inc. earningsMerck & Co., Inc.

    Anticipated earnings call for Merck & Co., Inc. ($MRK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoCARDINAL HEALTH INC earningsCARDINAL HEALTH INC

    Anticipated earnings call for CARDINAL HEALTH INC ($CAH).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoDEXCOM INC earningsDEXCOM INC

    Anticipated earnings call for DEXCOM INC ($DXCM).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoELI LILLY & Co earningsELI LILLY & Co

    Anticipated earnings call for ELI LILLY & Co ($LLY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoSTRYKER CORP earningsSTRYKER CORP

    Anticipated earnings call for STRYKER CORP ($SYK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoBRISTOL MYERS SQUIBB CO earningsBRISTOL MYERS SQUIBB CO

    Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoAMGEN INC earningsAMGEN INC

    Anticipated earnings call for AMGEN INC ($AMGN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoBIOMARIN PHARMACEUTICAL INC earningsBIOMARIN PHARMACEUTICAL INC

    Anticipated earnings call for BIOMARIN PHARMACEUTICAL INC ($BMRN).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoBAXTER INTERNATIONAL INC earningsBAXTER INTERNATIONAL INC

    Anticipated earnings call for BAXTER INTERNATIONAL INC ($BAX).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoCORCEPT THERAPEUTICS INC earningsCORCEPT THERAPEUTICS INC

    Anticipated earnings call for CORCEPT THERAPEUTICS INC ($CORT).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoTravere Therapeutics, Inc. earningsTravere Therapeutics, Inc.

    Anticipated earnings call for Travere Therapeutics, Inc. ($TVTX).

    full page →yahoo earnings ↗
    ← prev
    page 1 of 7
    next →
    $NVS155.01-0.72%
    $GSK51.35+1.20%
    $ABBV259.36+0.95%
    $ECL268.75+2.13%
    $REGN656.01+0.63%
    $INCY117.67+0.84%
    $AZN169.26+0.59%
    $ORN12.69-1.78%
    $TEVA30.81-1.19%
    $GKOS153.58+0.95%
    $BIIB202.19+0.78%
    $BLCO16.17+1.19%
    $SBAC173.57-0.73%
    $AGIO36.36+0.22%
    $IONS56.55+1.22%
    $AVTR11.44+0.79%
    $MMSI74.32+1.66%
    $MRK131.07+0.45%
    $CAH228.03+0.91%
    $DXCM71.54+1.50%
    $LLY1196.03+0.86%
    $SYK330.25+3.54%
    $BMY62.09+0.94%
    $AMGN376.04+1.22%
    $BMRN59.33+0.78%
    $BAX22.40+3.37%
    $CORT95.36-1.34%
    $TVTX57.36+1.20%